 Lung Neoplasms
"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 2 | 2 | 4 | | 1982 | 2 | 0 | 2 | | 1983 | 6 | 0 | 6 | | 1984 | 5 | 0 | 5 | | 1985 | 8 | 2 | 10 | | 1986 | 12 | 0 | 12 | | 1987 | 5 | 1 | 6 | | 1988 | 15 | 2 | 17 | | 1989 | 14 | 1 | 15 | | 1990 | 14 | 2 | 16 | | 1991 | 15 | 2 | 17 | | 1992 | 17 | 0 | 17 | | 1993 | 12 | 1 | 13 | | 1994 | 14 | 1 | 15 | | 1995 | 10 | 2 | 12 | | 1996 | 13 | 4 | 17 | | 1997 | 14 | 0 | 14 | | 1998 | 7 | 4 | 11 | | 1999 | 8 | 5 | 13 | | 2000 | 13 | 2 | 15 | | 2001 | 7 | 2 | 9 | | 2002 | 17 | 3 | 20 | | 2003 | 13 | 3 | 16 | | 2004 | 10 | 0 | 10 | | 2005 | 18 | 1 | 19 | | 2006 | 16 | 1 | 17 | | 2007 | 13 | 0 | 13 | | 2008 | 14 | 1 | 15 | | 2009 | 23 | 1 | 24 | | 2010 | 21 | 4 | 25 | | 2011 | 9 | 4 | 13 | | 2012 | 12 | 0 | 12 | | 2013 | 9 | 1 | 10 | | 2014 | 15 | 0 | 15 | | 2015 | 22 | 0 | 22 | | 2016 | 18 | 2 | 20 | | 2017 | 11 | 2 | 13 | | 2018 | 15 | 2 | 17 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Tierney JF, Kosche C, Schadde E, Ali A, Virmani S, Pappas SG, Poirier J, Keutgen XM. 68Gallium-DOTATATE positron emission tomography-computed tomography (PET CT) changes management in a majority of patients with neuroendocrine tumors. Surgery. 2019 01; 165(1):178-185.
-
Li CC, Matthews AK, Rywant MM, Hallgren E, Shah RC. Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking. Cancer Causes Control. 2019 Mar; 30(3):235-240.
-
Mulshine JL. One Screening for Ischemic Heart Disease, Lung Cancer, and Chronic Obstructive Pulmonary Disease: A Systems Biology Bridge for Tobacco and Radiation Exposure. Am J Public Health. 2018 10; 108(10):1294-1295.
-
Puri V, Gaissert HA, Wormuth DW, Grogan EL, Burfeind WR, Chang AC, Seder CW, Fernandez FG, Brown L, Magee MJ, Kosinski AS, Raymond DP, Broderick SR, Welsh RJ, DeCamp MM, Farjah F, Edwards MA, Kozower BD. Defining Proficiency for The Society of Thoracic Surgeons Participants Performing Thoracoscopic Lobectomy. Ann Thorac Surg. 2019 01; 107(1):202-208.
-
Arndt AT. A Little Bit of Cancer is Still Cancer: Is it Time for Lymph Node Micrometastases in Non-small Cell Lung Cancer to Get Their Due? Ann Surg Oncol. 2018 12; 25(13):3781-3782.
-
Chow AK, Kahan AN, Hwang T, Coogan CL, Latchamsetty KC. Should We Separate the Pulmonary Surveillance Protocol for Postsurgical T1a and T1b Renal Cell Carcinoma? A Multicenter Database Analysis. Urology. 2018 Dec; 122:127-132.
-
Dou Y, Zhu Y, Ai J, Chen H, Liu H, Borgia JA, Li X, Yang F, Jiang B, Wang J, Deng Y. Plasma small ncRNA pair panels as novel biomarkers for early-stage lung adenocarcinoma screening. BMC Genomics. 2018 Jul 20; 19(1):545.
-
Gadgeel SM, Pennell NA, Fidler MJ, Halmos B, Bonomi P, Stevenson J, Schneider B, Sukari A, Ventimiglia J, Chen W, Galasso C, Wozniak A, Boerner J, Kalemkerian GP. Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC). J Thorac Oncol. 2018 09; 13(9):1393-1399.
-
Bonomi P, Blumenthal G, Ferris AS, Stewart DJ, Selig WKD, Krug LM, Allen J, Ison G, Langer CJ, Melemed A, Odogwu L, Basu Roy U, Sandler A. Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria. J Thorac Oncol. 2018 06; 13(6):748-751.
-
Kanangat S, Seder CW, Pergande MR, Lobato GC, Fhied CL, Raouf MF, Liptay MJ, Borgia JA. Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions. Hum Immunol. 2018 Jul; 79(7):558-563.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|